1239775-52-0

Upstream product

• 51985-95-6 methyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate 
• 100-39-0 benzyl bromide 
• 1252658-19-7 methyl 5-(benzyloxy)-1-methyl-1H-pyrazole-3-carboxylate 

Downstream Products

• 1252658-20-0 1-{[5-(benzyloxy)-1-methyl-1H-pyrazol-3-yl]carbonyl}-4-(2-tert-butylphenyl)piperazine 
• 1252657-72-9 [(3-{[4-(2-tert-Butylphenyl)piperazin-1-yl]carbonyl}-1-methyl-1H-pyrazol-5-yl)oxy]acetic acid 
• 1252658-21-1 3-{[4-(2-tert-butylphenyl)piperazin-1-yl]carbonyl}-1-methyl-1H-pyrazol-5-ol 
• 1252658-22-2 (E) Methyl [(3-{[4-(2-tert-butylphenyl)piperazin-1-yl]carbonyl}-1-methyl-1H-pyrazol-5-yl)oxy]acetate 
• 1188541-36-7 C₂₅H₂₅F₃N₆O₃ 
• 1188541-37-8 8-{1-methyl-5-[3-(4-trifluoromethoxyphenyl)prop-2-ynyloxy]-1H-pyrazol-3-yl}-1,3-dipropyl-3,7-dihydropurine-2,6-dione 

Relevant academic research and scientific papers

DERIVATIVES OF N-ACYL-N'-PHENYLPIPERAZINE USEFUL (INTER ALIA) FOR THE PROPHYLAXIS OR TREATMENT OF DIABETES

The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present specification, which has a superior RBP4-lowering action and is useful as a pharmaceutical composition for the prophylaxis or treatment of a disease or condition mediated by an increase in RBP4.